Cargando…

Prevalence of asymptomatic SARS-CoV-2 infection in an Austrian cohort

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first emerged at the end of 2019, causing the coronavirus disease (COVID-19). The main sources of infections are infected and asymptomatic persons. One major problem of the pandemic are the diverse symptoms and the varying manifestations o...

Descripción completa

Detalles Bibliográficos
Autores principales: Mara, Elisabeth, Breitsching, Verena, Schuster, Tanja, Pekar, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496944/
http://dx.doi.org/10.1016/j.clicom.2021.08.002
_version_ 1784579857365073920
author Mara, Elisabeth
Breitsching, Verena
Schuster, Tanja
Pekar, Thomas
author_facet Mara, Elisabeth
Breitsching, Verena
Schuster, Tanja
Pekar, Thomas
author_sort Mara, Elisabeth
collection PubMed
description Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first emerged at the end of 2019, causing the coronavirus disease (COVID-19). The main sources of infections are infected and asymptomatic persons. One major problem of the pandemic are the diverse symptoms and the varying manifestations of the illness. In this study, the IgG level recognizing the RBD of SARS-CoV-2 was determined within 336 volunteers from the environment of the University of Applied Sciences Wiener Neustadt. The aims of this study were to identify the estimated number of undiscovered COVID-19 infections and the corresponding antibody levels. In total, 11.3% of the nonvaccinated probands had a positive IgG antibody titer against SARS-CoV-2, whereas 4.0% did not test positive for SARS-CoV-2 or had never been tested at the time of sampling. Probands in this study reported tiredness (57,5%), ageusia/anosmia (55%) and headache (47,5%) as most frequent symptoms.
format Online
Article
Text
id pubmed-8496944
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Authors. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-84969442021-10-08 Prevalence of asymptomatic SARS-CoV-2 infection in an Austrian cohort Mara, Elisabeth Breitsching, Verena Schuster, Tanja Pekar, Thomas Clinical Immunology Communications Short Communication Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first emerged at the end of 2019, causing the coronavirus disease (COVID-19). The main sources of infections are infected and asymptomatic persons. One major problem of the pandemic are the diverse symptoms and the varying manifestations of the illness. In this study, the IgG level recognizing the RBD of SARS-CoV-2 was determined within 336 volunteers from the environment of the University of Applied Sciences Wiener Neustadt. The aims of this study were to identify the estimated number of undiscovered COVID-19 infections and the corresponding antibody levels. In total, 11.3% of the nonvaccinated probands had a positive IgG antibody titer against SARS-CoV-2, whereas 4.0% did not test positive for SARS-CoV-2 or had never been tested at the time of sampling. Probands in this study reported tiredness (57,5%), ageusia/anosmia (55%) and headache (47,5%) as most frequent symptoms. The Authors. Published by Elsevier Inc. 2021-12 2021-10-07 /pmc/articles/PMC8496944/ http://dx.doi.org/10.1016/j.clicom.2021.08.002 Text en © 2021 The Authors. Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Short Communication
Mara, Elisabeth
Breitsching, Verena
Schuster, Tanja
Pekar, Thomas
Prevalence of asymptomatic SARS-CoV-2 infection in an Austrian cohort
title Prevalence of asymptomatic SARS-CoV-2 infection in an Austrian cohort
title_full Prevalence of asymptomatic SARS-CoV-2 infection in an Austrian cohort
title_fullStr Prevalence of asymptomatic SARS-CoV-2 infection in an Austrian cohort
title_full_unstemmed Prevalence of asymptomatic SARS-CoV-2 infection in an Austrian cohort
title_short Prevalence of asymptomatic SARS-CoV-2 infection in an Austrian cohort
title_sort prevalence of asymptomatic sars-cov-2 infection in an austrian cohort
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496944/
http://dx.doi.org/10.1016/j.clicom.2021.08.002
work_keys_str_mv AT maraelisabeth prevalenceofasymptomaticsarscov2infectioninanaustriancohort
AT breitschingverena prevalenceofasymptomaticsarscov2infectioninanaustriancohort
AT schustertanja prevalenceofasymptomaticsarscov2infectioninanaustriancohort
AT pekarthomas prevalenceofasymptomaticsarscov2infectioninanaustriancohort